CN Patent
CN101132775A — 替加环素组合物及制备方法
Assigned to Wyeth LLC · Expires 2008-02-27 · 18y expired
What this patent protects
本发明涉及固体状态和液态状态下稳定性提高的新的替加环素组合物和制备这些组合物的方法。这些组合物包含替加环素、适当的碳水化合物以及酸或缓冲剂。
USPTO Abstract
本发明涉及固体状态和液态状态下稳定性提高的新的替加环素组合物和制备这些组合物的方法。这些组合物包含替加环素、适当的碳水化合物以及酸或缓冲剂。
Drugs covered by this patent
- Tygacil (TIGECYCLINE) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.